Related Experiment Video
Updated: Jun 6, 2025

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Biofilm Production in Intensive Care Units: Challenges and Implications
Ferdiye Taner1,2, Buket Baddal1,2, Liana Theodoridis3
1Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, 99138 Nicosia, Cyprus.
Abstract:
The prevalence of infections amongst intensive care unit (ICU) patients is inevitably high, and the ICU is considered the epicenter for the spread of multidrug-resistant bacteria. Multiple studies have focused on the microbial diversity largely inhabiting ICUs that continues to flourish despite treatment with various antibiotics, investigating the factors that influence the spread of these pathogens, with the aim of implementing sufficient monitoring and infection control methods. Despite joint efforts from healthcare providers and policymakers, ICUs remain a hub for healthcare-associated infections. While persistence is a unique strategy used by these pathogens, multiple other factors can lead to persistent infections and antimicrobial tolerance in the ICU. Despite the recognition of the detrimental effects biofilm-producing pathogens have on ICU patients, overcoming biofilm formation in ICUs continues to be a challenge. This review focuses on various facets of ICUs that may contribute to and/or enhance biofilm production. A comprehensive survey of the literature reveals the apparent need for additional molecular studies to assist in understanding the relationship between biofilm regulation and the adaptive behavior of pathogens in the ICU environment. A better understanding of the interplay between biofilm production and antibiotic resistance within the environmental cues exhibited particularly by the ICU may also reveal ways to limit biofilm production and indivertibly control the spread of antibiotic-resistant pathogens in ICUs.
Insights
Intensive care units (ICUs) are hotspots for multidrug-resistant bacteria and healthcare-associated infections. This review explores how ICU environments promote biofilm formation, aiding pathogen persistence and antibiotic resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Intensive care units (ICUs) are high-risk environments for infections, particularly those caused by multidrug-resistant bacteria.
- Healthcare-associated infections (HAIs) are prevalent in ICUs despite ongoing efforts in monitoring and infection control.
- Biofilm formation by pathogens is a significant challenge in ICUs, contributing to persistent infections and antimicrobial tolerance.
Purpose of the Study:
- To review the factors within the ICU environment that contribute to and enhance biofilm production by pathogens.
- To highlight the need for further molecular research into biofilm regulation and pathogen adaptation in ICUs.
- To explore the relationship between biofilm production, antibiotic resistance, and ICU environmental cues.
Main Methods:
- Comprehensive literature review of studies on microbial diversity, pathogen spread, and infection control in ICUs.
- Analysis of factors influencing biofilm formation and persistence in the ICU setting.
- Examination of the interplay between environmental cues, biofilm production, and antimicrobial resistance.
Main Results:
- ICU environments harbor microbial diversity that persists despite antibiotic treatments.
- Biofilm-producing pathogens pose a significant threat, with their formation being a persistent challenge in ICUs.
- Understanding the ICU's role in promoting biofilm production and antibiotic resistance is crucial.
Conclusions:
- ICU environments play a critical role in fostering biofilm production and the spread of antibiotic-resistant pathogens.
- Additional molecular studies are needed to elucidate the mechanisms of biofilm regulation and pathogen adaptation in ICUs.
- Targeting biofilm formation within the ICU context may be a key strategy to control persistent infections and reduce antimicrobial resistance.
More Related Videos
05:03Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model
Published on: December 14, 2016
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Biofilms
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...